| 000 | 01334 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513061226.0 | ||
| 264 | 0 | _c19930617 | |
| 008 | 199306s 0 0 eng d | ||
| 022 | _a0022-3573 | ||
| 024 | 7 |
_a10.1111/j.2042-7158.1993.tb05547.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShameem, M | |
| 245 | 0 | 0 |
_aAn in-vitro and in-vivo correlative approach to the evaluation of ester prodrugs to improve oral delivery of propranolol. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacy and pharmacology _cApr 1993 |
||
| 300 |
_a246-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 | _aHydrolysis |
| 650 | 0 | 4 |
_aLiver _xmetabolism |
| 650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
| 650 | 0 | 4 |
_aProdrugs _xadministration & dosage |
| 650 | 0 | 4 |
_aPropranolol _xadministration & dosage |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aImai, T | |
| 700 | 1 | _aOtagiri, M | |
| 773 | 0 |
_tThe Journal of pharmacy and pharmacology _gvol. 45 _gno. 4 _gp. 246-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.2042-7158.1993.tb05547.x _zAvailable from publisher's website |
| 999 |
_c8097684 _d8097684 |
||